(Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | (Q1)Aug 31, 2023 | (FY)May 31, 2023 | (Q4)May 31, 2023 | (Q3)Feb 28, 2023 | (Q2)Nov 30, 2022 | (Q1)Aug 31, 2022 | (FY)May 31, 2022 | (Q4)May 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -26.9K | 108.78%7.13K | 60.65%-101.22K | -3,632.23%-535.54K | -498.92%-197.18K | 0 | -23,346.82%-81.13K | -537.72%-257.23K | -14.35K | 49.43K |
Net income from continuing operations | ---51.47K | 13.69%-52.2K | 71.76%-67.56K | -424.37%-608.26K | -315.00%-308.52K | --0 | -476.79%-60.48K | -3,311.65%-239.26K | ---116K | ---74.34K |
Asset impairment expenditure | ---- | ---- | ---- | --80K | ---- | ---- | ---- | ---- | ---- | ---- |
Remuneration paid in stock | --0 | --0 | --0 | 1,380.97%154.02K | 956.68%82.42K | --0 | --0 | --71.6K | --10.4K | --7.8K |
Change In working capital | --24.57K | 387.28%59.32K | 62.42%-33.66K | -276.77%-161.3K | -144.04%-51.08K | --0 | -303.67%-20.65K | -168.80%-89.57K | --91.25K | --115.97K |
-Change in receivables | --16.29K | 277.71%9.72K | -565.09%-65K | -332.77%-26.24K | -1,971.75%-11K | --0 | -1,250.12%-5.47K | -179.02%-9.77K | --11.27K | ---531 |
-Change in prepaid assets | --22.49K | 224.13%29.17K | 4,589.20%33.67K | -1,406.92%-75.33K | ---51.08K | --0 | -570.00%-23.5K | 92.50%-750 | ---5K | --0 |
-Change in payables and accrued expense | ---14.21K | 145.70%20.44K | 97.05%-2.33K | -170.29%-59.73K | -90.55%11K | --0 | 50.04%8.32K | -121.48%-79.05K | --84.97K | --116.5K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | ---26.9K | 108.78%7.13K | 60.65%-101.22K | -3,632.23%-535.54K | -498.92%-197.18K | --0 | -23,346.82%-81.13K | -537.72%-257.23K | ---14.35K | --49.43K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | -580.00%-68K | 0 | -231.25%-132.5K | -125.00%-90K | 0 | -10K | -32.5K | -40K | -40K |
Net PPE purchase and sale | --0 | -580.00%-68K | --0 | -231.25%-132.5K | -125.00%-90K | --0 | ---10K | ---32.5K | ---40K | ---40K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | -580.00%-68K | --0 | -231.25%-132.5K | -125.00%-90K | --0 | ---10K | ---32.5K | ---40K | ---40K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 0 | -96.68%15K | 939.19K | 487.3K | 0 | 0 | 451.88K | 0 | 0 |
Net common stock issuance | --0 | --0 | --0 | --1.08M | --623.12K | --0 | --0 | --451.88K | --0 | --0 |
Proceeds from stock option exercised by employees | --0 | --0 | --15K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net other financing activities | ---- | ---- | ---- | ---135.81K | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | --0 | -96.68%15K | --939.19K | --487.3K | --0 | --0 | --451.88K | --0 | --0 |
Net cash flow | ||||||||||
Beginning cash position | 59.96%141.48K | 12.68%202.35K | 1,556.09%288.57K | -75.72%17.43K | 1,006.17%88.45K | 184.48%88.45K | 471.20%179.58K | -75.72%17.43K | --71.77K | --8K |
Current changes in cash | ---26.9K | 33.20%-60.87K | -153.17%-86.22K | 598.90%271.15K | 2,022.44%200.13K | --0 | -26,236.99%-91.13K | 502.00%162.15K | ---54.35K | --9.43K |
End cash Position | 29.54%114.58K | 59.96%141.48K | 12.68%202.35K | 1,556.09%288.57K | 1,556.09%288.57K | 1,006.17%88.45K | 184.48%88.45K | 471.20%179.58K | --17.43K | --17.43K |
Free cash from | ---26.9K | 33.20%-60.87K | 65.06%-101.22K | -1,129.16%-668.04K | -3,145.71%-287.18K | --0 | -26,236.99%-91.13K | -618.30%-289.73K | ---54.35K | --9.43K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.